Zubair Khalid

Virologist/Molecular Biologist | Veterinarian | Bioinformatician

Conventional & Molecular Virology • Vaccine Development • Computational Biology

Dr. Zubair Khalid is a veterinarian and virologist specializing in conventional and molecular virology, vaccine development, and computational biology. Dedicated to advancing animal health through innovative research and multi-omics approaches.

Dr. Zubair Khalid - Veterinarian, Virologist, and Vaccine Development Researcher specializing in Computational Biology, Multi-omics, Animal Health, and Infectious Disease Research

Category: Guides

Experimental Quic Protocol: A Practical Guide to RT-QuIC for Prion and Synucleinopathy Diagnostics

Real-time quaking induced conversion (RT-QuIC) is a highly sensitive in vitro amplification assay that detects misfolded prion and amyloidogenic proteins in patient samples. It is the current gold standard for diagnosing prion diseases and is rapidly being adapted for alpha-synucleinopathies such as Parkinson disease. This guide is written for laboratory scientists, clinical researchers, and bioinformaticians who need a source bounded framework to understand, implement, or evaluate RT-QuIC protocols in their own workflows. The core principle is straightforward: add a sample containing aggregated seed protein to a well with recombinant monomeric substrate, incubate with intermittent shaking, and monitor thioflavin T fluorescence as misfolded aggregates grow. NCBI Bookshelf provides a foundational reference for the biochemistry of protein misfolding, while the clinical context is detailed in recent landmark studies on diagnostic stewardship for parkinsonism. Biomarkers stewardship in parkinsonism

RT-QuIC is not yet a fully standardized clinical test across all applications, but the experimental protocol is mature enough for research use and for clinical trials that require longitudinal biomarkers. This guide will walk you through the core concepts, decision points, a practical workflow, quality checks, common mistakes, and the limits of interpretation.

At a Glance

Aspect Key Points
Core concept Misfolded protein seeds catalyze conversion of recombinant monomeric substrate into amyloid fibrils, detected by real time fluorescence
Typical substrate Full length recombinant prion protein (for prion RT QuIC) or alpha synuclein (for synuclein RT QuIC)
Sample types Cerebrospinal fluid (CSF), skin biopsies, hair roots, olfactory mucosa, brain tissue homogenates
Readout Thioflavin T fluorescence curves recorded every 15 45 minutes, positive defined by sigmoidal rise above threshold
Turnaround time 1 to 3 days depending on seed concentration and substrate quality
Key advantages Sensitivity often >90%, specificity >95% for sporadic Creutzfeldt Jakob disease, applicable to other proteinopathies
Main limitations Requires careful control of shaking conditions, substrate batch effects, and false negatives in low seed concentration samples

Decision Criteria: When to Choose RT-QuIC

RT-QuIC should be selected over immunoassays, conventional protein misfolding cyclic amplification (PMCA), or histopathology when you need to detect extremely low quantities of misfolded seeds in bodily fluids. The assay amplifies a single seed by orders of magnitude, which is impossible with antibody based detection. RT-QuIC: a highly promising diagnostic method outlines these advantages in detail.

Use RT-QuIC when:

  • You are diagnosing sporadic Creutzfeldt Jakob disease from CSF or olfactory mucosa. Sensitivity approaches 95% in experienced laboratories.
  • You need to differentiate rapidly progressive dementia from other causes. The test is more specific than 14 3 3 protein or tau ratios.
  • You are working with alpha-synuclein seed detection in Parkinson disease, multiple system atrophy, or dementia with Lewy bodies. Seed amplification assays are concordant with autopsy findings at high rates.
  • Your sample volume is limited (e.g., 100 µL of CSF or a single hair root). A noninvasive test for human prion disease using hair roots demonstrates this application.

Avoid RT-QuIC when:

  • You need rapid results (same day). The assay requires 12 to 72 hours of incubation.
  • Your laboratory cannot control shaker temperature within 0.5°C. Temperature drift is a major cause of false negatives.
  • You are testing samples with known matrix interference (e.g., heavily hemolyzed CSF or samples with high protease activity).
  • You need quantitative seed concentration. RT-QuIC is qualitative or semiquantitative at best, true concentrations require digital droplet or endpoint dilution methods.

Practical Workflow: From Sample to Interpretation

The protocol below follows the consensus method described in the literature and in training materials from EMBL EBI. EMBL-EBI Training offers relevant modules on protein aggregation assays. The workflow assumes you have access to a plate reader with fluorescence detection and temperature controlled shaking.

Step 1: Prepare Reagents and Substrate

Recombinant protein substrate must be monomeric. For prion RT QuIC, use full length recombinant hamster or human prion protein (PrP 23 231) expressed in E.coli. For synuclein RT QuIC, use recombinant alpha-synuclein (monomeric). Purify by ion exchange or size exclusion chromatography. Store small aliquots at -80°C. Bioconductor documentation on protein sequence analysis can help verify substrate quality using circular dichroism or light scattering.

Prepare assay buffer: 100 mM phosphate buffer pH 7.4, 130 mM NaCl, 1 mM EDTA, 0.1% SDS (for prion RT QuIC) or 0.01% SDS (for synuclein RT QuIC). Add 10 µM thioflavin T. Filter through 0.22 µm membrane.

Step 2: Load the Plate

Use black, clear bottom, non treated 384 well plates. Add 100 µL of master mix (substrate in assay buffer, 0.1 mg/mL final for PrP, 0.5 mg/mL for synuclein) to each well. Add 2 to 10 µL of sample (CSF, tissue homogenate, or hair root extract). Include at least 8 negative controls (buffer only, recombinant substrate only) and 2 positive controls (known diseased brain homogenate or recombinant seeds). The comparative study in chronic wasting disease used triplicates for each sample. Comparative study of immunoassays and RT-QuIC

Step 3: Incubate with Shaking

Seal the plate with a foil seal to prevent evaporation. Place in a plate reader preheated to 42°C for prion RT QuIC or 37°C for synuclein RT QuIC. Program a double orbital shake cycle: 1 minute shaking (700 rpm) followed by 1 minute rest, repeated for 60 to 90 hours. Measure fluorescence (ex 450 nm, em 480 nm) every 15 minutes.

Step 4: Analyze Fluorescence Curves

Export raw fluorescence data. Subtract baseline (average of first 5 readings). Apply a threshold: typically 3 to 5 standard deviations above the mean of negative controls at the same time point. A well is positive if the fluorescence exceeds threshold within 60 hours and shows a sigmoidal shape.

The Galaxy Training Network offers workflows for analyzing time course data. Galaxy Training Network You can use their tools to calculate lag phase, maximum fluorescence, and slope. For clinical reporting, use a binary outcome (positive or negative) based on two independent readers.

Step 5: Confirm with Specificity Controls

Positive samples should be tested with an additional well containing the same sample plus a monoclonal antibody that blocks seed elongation (for prion RT QuIC, antibody 3F4). If fluorescence is suppressed, the signal is specific. For synuclein, use a seed specific antibody or digest with proteinase K before amplification.

Quality Checks

Every run must meet three quality criteria. First, all negative controls must remain flat (no sigmoidal rise) for the entire incubation. Second, the positive control must reach half maximum fluorescence before 40 hours. Third, the coefficient of variation for replicate wells of a known positive control must be below 20%.

Run a side by side comparison with your reference laboratory at least quarterly. The recent systematic comparison of alpha-synuclein seed amplification assays highlights that differences in substrate source, shaking frequency, and SDS concentration cause interlaboratory variability. A Systematic Comparison of Alpha-Synuclein Seed Amplification Assays Use the same batch of substrate for all samples in a study.

Store raw fluorescence data as tab separated files. Upload them to the NCBI Sequence Read Archive as supplementary data using the BioProject accession system. NCBI Sequence Read Archive This ensures reproducibility and allows others to reanalyze your curves.

Common Mistakes

Material contaminated with exogenous seeds. This is the most frequent source of false positives. Use dedicated pipettes that never touch recombinant prion or synuclein. Prepare master mix in a separate room. Wear gloves and a lab coat that never contact brain homogeneous. Change filter tips between every well.

Substrate batch failure. Recombinant protein can contain preformed aggregates even after extensive purification. Always test each new batch with a panel of 10 known positives and 10 known negatives. Reject batches that produce late fluorescence in negative controls.

Overinterpretation of late fluorescence signals. Some samples show a fluorescence rise after 80 hours. These are often artifacts from evaporation, bacterial growth, or substrate precipitation. Set a strict termination time (e.g., 60 hours). Do not read the plate beyond 72 hours.

Improper shaking speed. Too slow shaking reduces seed substrate contact. Too fast shaking generates air bubbles that scatter light and produce erratic fluorescence. Use 700 rpm for 1 minute alternating with 1 minute rest. Validate shaking speed with an accelerometer or a dye mixing test.

Limits of Interpretation

RT-QuIC is a binary or semiquantitative assay. The lag phase and maximum fluorescence do not correlate linearly with seed concentration across all sample types. You cannot directly compare fluorescence values between different runs unless you normalize to an internal standard. The assay does not distinguish between different prion strains or between synucleinopathies (Parkinson disease vs. multiple system atrophy) unless you use conformational specific antibodies or differential SDS concentrations.

False negatives occur in approximately 5% of sporadic Creutzfeldt Jakob disease cases, especially in variant CJD or genetic forms with low prion seed load. For synucleinopathies, CSF based RT-QuIC is less sensitive in multiple system atrophy than in Parkinson disease. The assay is not yet validated for blood, urine, or saliva outside of research settings.

The clinical interpretation must always consider the pretest probability. A positive RT-QuIC in a patient with rapidly progressive dementia strongly supports prion disease, but a negative result does not rule it out. Combined use with neurofilament light chain and MRI improves diagnostic accuracy, as outlined in a recent stewardship framework. Alzheimer's Association ARIA workgroup discusses how diagnostic tests like RT-QuIC fit into broader clinical algorithms for neurodegeneration.

Frequently Asked Questions

1. Can I use brain homogenate instead of CSF for RT-QuIC? Yes. Brain tissue contains a higher concentration of seeds, giving faster amplification and stronger fluorescence. However, the clinical utility lies in antemortem diagnosis from CSF, skin, or nasal brushings. Brain homogenate is best reserved for confirmatory testing postmortem.

2. How do I store and ship CSF for RT-QuIC? Freeze the CSF within 2 hours of collection at -80°C. Ship on dry ice. Avoid freeze thaw cycles, aliquoting into single use vials is essential. Storage at -20°C for more than one month reduces seed activity by 30 to 50 percent.

3. Why do my negative controls sometimes show fluorescence after 50 hours? Late fluorescence in negative controls usually indicates that the recombinant substrate contained preformed aggregates. Filter the substrate through a 0.22 µm membrane before use. Also check that the plate sealer is intact and that condensation droplets are not scattering light.

4. Can RT-QuIC be multiplexed for both prion and synuclein seeds in the same well? Not with the current protocol. The two proteins require different substrates, buffers, and temperatures. You can run parallel plates with separate master mixes. Some groups use two color fluorescence (e.g., thioflavin T for prions and a different amyloid dye for synuclein) but this is experimental and not validated.

References and Further Reading

Related Articles